Chemotherapy-Induced Peripheral Neuropathic Pain in Cancer Patients/Survivors
DOI:
https://doi.org/10.20344/amp.18750Keywords:
Antineoplastic Agents/adverse effects, Cancer Survivors, Neuralgia/etiology, Peripheral Nervous System Diseases/chemically inducedAbstract
N/a.
Downloads
References
Direção-Geral da Saúde. Norma 043/2011 (Atualização de 13/07/2017): Tratamento farmacológico da dor neuropática no adulto e idoso. [consultado 2021 abr 15]. Disponível em: https://nocs.pt/dorneuropatica-adulto-e-idoso/.
Edwards HL, Mulvey MR, Bennett MI. Cancer-related neuropathic pain. Cancers. 2019;11:373. DOI: https://doi.org/10.3390/cancers11030373
Kerckhove N, Collin A, Condé S, Chaleteix C, Pezet D, Balayssac D. Long-term effects, pathophysiological mechanisms, and risk factors of chemotherapy-induced peripheral neuropathies: a comprehensive literature review. Front Pharmacol. 2017;8:86. DOI: https://doi.org/10.3389/fphar.2017.00086
Zajączkowska R, Kocot-Kępska M, Leppert W, Wrzosek A, Mika J, Wordliczek J. Mechanisms of chemotherapy-induced peripheral neuropathy. Int J Mol Sci. 2019;20:1451. DOI: https://doi.org/10.3390/ijms20061451
Quintão NL, Santin JR, Stoeberl LC, Corrêa TP, Melato J, Costa R. Pharmacological treatment of chemotherapy-induced neuropathic pain: PPARγ agonists as a promising tool. Front Neurosci. 2019;13:907. DOI: https://doi.org/10.3389/fnins.2019.00907
Burgess J, Ferdousi M, Gosal D, Boon C, Matsumoto K, Marshall A, et al. Chemotherapy-induced peripheral neuropathy: epidemiology, pathomechanisms and treatment. Oncol Ther. 2021;9:385-450. DOI: https://doi.org/10.1007/s40487-021-00168-y
Staff NP, Grisold A, Grisold W, Windebank AJ. Chemotherapy-inducedperipheral neuropathy: a current review. Ann Neurol. 2017;81:772-81. DOI: https://doi.org/10.1002/ana.24951
Guimarães J, Silveira F. Abordagem diagnóstica das neuropatias periféricas. Acta Med Port. 2008;21:83-8.
Jordan B, Margulies A, Cardoso F, Cavaletti G, Haugnes HS, Jahn P, et al. Systemic anticancer therapy-induced peripheral and central neurotoxicity: ESMO–EONS–EANO Clinical Practice Guidelines for diagnosis, prevention, treatment and follow-up. Ann Oncol. 2020;31:1306-19. DOI: https://doi.org/10.1016/j.annonc.2020.07.003
Loprinzi CL, Lacchetti C, Bleeker J, Cavaletti G, Chauhan C, Hertz DL, et al. Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: ASCO Guideline Update. J Clin Oncol. 2020;38: 3325-48. DOI: https://doi.org/10.1200/JCO.20.01399
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Acta Médica Portuguesa
![Creative Commons License](http://i.creativecommons.org/l/by-nc/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.
It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.
Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.
After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.